Early-stage characterization and selection of immuno-oncology leads through in-vitro cell-based assays and beyond
24 Sep 2024
Muir Woods
Translational Research
)
- From checkpoint inhibitors towards neoepitope vaccines, does one size fits it all?
- Fit for purpose in vitro assay development
- Early characterization and immunogenicity testing of lead candidates
- Non human primate in vitro assays
Industry Expert
